$82.50—Stale · unknown old
NYSE • Last print unknown ago
$82.50—Stale · unknown old
Fidelity MSCI Health Care Index ETF (FHLC) provides investors with exposure to a diverse range of U.S. health care companies, including pharmaceuticals, biotechnology, and medical devices. The ETF's competitive position is bolstered by its low expense ratio and broad market coverage, which allows it to capture the growth potential of the health care sector effectively.
FHLC generates revenue primarily through management fees based on the total assets under management. Its competitive advantages include a low expense ratio compared to peers, a passive investment strategy that tracks the MSCI USA IMI Health Care 25/50 Index, and Fidelity's strong brand reputation in the asset management industry.
Changes in health care sector performance, particularly large-cap stocks like Johnson & Johnson and Pfizer
Market sentiment towards health care innovation and biotechnology advancements
Regulatory changes impacting the health care industry
Interest rate fluctuations affecting investment flows into ETFs
Technological disruption in health care delivery and pharmaceuticals
Regulatory changes affecting drug pricing and reimbursement
Increased competition from other low-cost ETFs and index funds
Potential market share loss to actively managed health care funds
Minimal debt exposure as an ETF, but underlying companies may face financial risks
moderate - The health care sector is generally resilient during economic downturns, but discretionary health spending can be affected by consumer confidence.
Rising interest rates can lead to increased borrowing costs for health care companies, potentially impacting their profitability and stock performance, which in turn affects the ETF's value.
minimal - The ETF is not directly dependent on credit markets, but broader credit conditions can influence the performance of underlying health care stocks.
growth - Investors seeking exposure to the growing health care sector and its innovation potential.
moderate - The ETF's beta is typically around 0.8, indicating lower volatility compared to the broader market.